Also catching up on all the Aytu Merger and Acquisition activity. So looks like big growth in revenue and staff was already expected unrelated to recent COVID-19 developments. Add the debt (which I’d expect to be reduced significantly from offerings), with unexpected surge of COVID-19 test revenue from USA, Canada, and Mexico, plus strategic alliance rumors... could be looking at a ridiculously amazing +EBITDA situation. Oh Joy. So happy to park more big boy dollars right here and wait for the May Earnings call. Gonna be a good one me thinks.